Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2758 per EA under NDC 65862073730. Its NADAC has been published 515 times since Oct 12, 2016.
FDA first approved this application on Apr 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 160 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862073730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206512FDA Approved
4/22/2016
TE Code
AB
On Market Since
4/22/2016
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 515 times since Oct 12, 2016, and over the history we have for it it has declined 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2758 per EA |
|---|---|
| All-time high | $0.5411 (Jan 11, 2017) |
| All-time low | $0.2758 (Aug 19, 2026) |
| 52-week high | $0.4927 |
| 52-week low | $0.2758 |
| Median price | $0.4532 |
| Average price | $0.4501 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 515 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and valsartan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Aurobindo Pharma Limited, is $0.2758 per EA (NDC 65862073730), effective Aug 19, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 48.3%. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Oct 12, 2016, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.2758 (Aug 19, 2026) to a high of $0.5411 (Jan 11, 2017), with a median of $0.4532 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN 5-160 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 65862073730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.